Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_assertion type Assertion NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_head.
- NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_assertion description "[Our data do not show a survival advantage for type 2 diabetes hemodialysis patients receiving RAS inhibiting therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_provenance.
- NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_assertion evidence source_evidence_literature NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_provenance.
- NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_assertion SIO_000772 15946912 NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_provenance.
- NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_assertion wasDerivedFrom gad-20150221 NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_provenance.
- NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_assertion wasGeneratedBy ECO_0000203 NP93312.RALSrtHPK6-ksRlvUfMVV-VptQtwCfdrZexYlRJCuEZLI130_provenance.